4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-014273
Chief Financial Officer sold 751 shares at an average $56.39 ($42,347)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2025-02-12 | Sale 10b5-1 | −739 | $56.39 | $41,672 | 105,556 | D |
| Smith Hunter C Chief Financial Officer | 2025-02-12 | Sale 10b5-1 | −12 | $56.22 | $675 | 105,544 | D |
| Open-market sales · 751 sh · avg $56.39 · $42,347 | |||||||
Loading xslF345X05/tm256729-3_4seq1.xml…